Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstanbul Galata University

About this trial

The World Health Organization (WHO) defines digital health as the field of knowledge and application related to any aspect of the adoption of digital technology in the stages of improvement. The combination of digital health with technology brings about a new transformation in digital media. This transformation allows for the development of communication and information in health services, the ability to conduct health-related research on digital media and the evaluation of this data. The ease of access to information and the provision of a timely feedback mechanism in the face of problems have enabled the spread of digital health systems, and have also enabled chronic disease management and epidemic disease monitoring.

It is recommended that the term digital readiness be used to cover the combination of digital access and use, digital literacy and digital health literacy. Digital health readiness is also defined as the main determinant of health and is thought to contribute to the improvement of health processes with the development of digital health literacy and to be a useful solution against health problems that may arise in the follow-up of chronic diseases.

Although there are tools in the literature that evaluate digital health readiness, there is no Turkish assessment tool that facilitates the follow-up of non-communicable chronic diseases. Therefore, the aim of our study is to evaluate the translation, validity, and reliability of the Digital Health Readiness Questionaire into Turkish in individuals with chronic non-infectious diseases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The study will include people over the age of 18, native Turkish speakers, literate, obese, diabetic, cardiovascular and respiratory patients.

Disqualifiers

Individuals with insufficient cooperation (Mini Mental Test score <24) and any cognitive problems that may prevent the administration of the survey will be excluded from the study.

Trial population

This study aimed to include 200 participants who applied as patients to Istanbul Faculty of Medicine, Department of Internal Medical Sciences, Department of Internal Medicine, Diabetes and Obesity Polyclinic and Istanbul Florence Nightingale Hospital, Department of Cardiovascular Surgery between September 2024 and August 2025 and met the inclusion criteria, based on the ethics committee approvals obtained from Biruni University Clinical Research Ethics Committee, decision number 2015-KAEK-68-22-01 dated 28.07.2022, and the ethics committee approvals obtained from Biruni University Non-Interventional Clinical Research Ethics Committee, decision number 2023/85-65 dated 22.12.2023.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Survey using a questionnaire.

    Other intervention

    It is a validity and reliability study that can evaluate digital health readiness.

  • Survey using a questionnaire.

    Other intervention

    This is a reliability and validity study.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Translation of the digital health readiness questionnaire

Translation of the digital health readiness questionnaire into Turkish and application on the sample

Time frame
1 month

Secondary outcomes

1

the validity and reliability of the survey in Turkish

To evaluate the translation, validity and reliability of the Digital Health Readiness Survey into Turkish in individuals with chronic non-communicable diseases.

Time frame
11 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Istanbul Galata University

Lead sponsor

Biruni University

Collaborator

Istanbul University - Cerrahpasa

Collaborator